Victoza is not FDA-approved to promote weight loss
Treatment with semaglutide tablets 14 mg once daily for 26 weeks resulted in a statistically significant reduction in HbA 1c from baseline compared to placebo (see Table 8 )
The recurring trap of this comparison is that the two compounds have never shared a trial so the honest answer to which is better? is that the evidence does not say
(B) Semaglutide, as a GLP-1 analog, can directly act on fat cells, increase the expression of thermogenic genes for browning phenotype maintenance, improve the expression of uncoupling protein 1 (UCP1), mitochondrial biosynthesis, and thermogenic marker, or promote fatty browning through nitric oxide synthase (NOS), neuropeptides (NPs), sirtuin 1 (STRT1), signal transducer and activator of transcription 3 (STAT3), and bone morphogenetic protein 4 (BMP4) signaling
Silicon accumulation and distribution in petunia and sunflower grown in a rice hull-amended substrate